Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
09/2010
09/23/2010US20100240881 Therapeutic compositions
09/23/2010US20100240694 Salt of naphthyridine carboxylic acid derivative
09/23/2010US20100239694 compositions of Acai fruit and Jucara fruit with high antioxidant capability and cyclooxygenase-inhibitory activity, and their uses
09/23/2010US20100239607 Compositions for inducing immune responses
09/22/2010EP2230299A1 Novel cytokine ZCYTOR17 ligand
09/22/2010EP2229955A1 Fibroblast growth factor receptor-1 inhibitors and methods of treatment using the same
09/22/2010EP1618092B1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
09/22/2010EP1617803B1 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
09/22/2010EP1554301B1 Dengue vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1 and 2.
09/22/2010CN101838326A Use of the CATHELICIDIN LL-37 and derivatives thereof for wound healing
09/22/2010CN101838271A Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
09/22/2010CN101838261A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
09/21/2010US7799900 humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases; treatment of B-cell associated diseases
09/21/2010US7799808 such as 2-bromo-1-[6-(4-methyl-imidazole-1-yl)-pyridin-3-yl]-ethanone, which have activity in modulating levels of amyloid-beta, useful in the treatment of neurodegenerative diseases, such as Alzheimer's disease
09/21/2010US7799803 Hydroxamic acid compounds and methods of use thereof
09/21/2010US7799800 Lipid-modified immune response modifiers
09/21/2010US7799782 P38 inhibitors and methods of use thereof
09/21/2010US7799774 Quinoline derivatives and their use as 5-HT6 ligands
09/21/2010US7799528 determining whether a first population of human cells comprises CD34+CD38-Lin- hematopoietic stem cells isolated from normal human bone marrow, cord blood, and peripheral blood stem cell preparations
09/21/2010US7799354 compositions of Acai fruit and Jucara fruit with high antioxidant capability and cyclooxygenase-inhibitory activity, and their uses
09/21/2010CA2405002C Antitumoral analogs of et-743
09/16/2010US20100234305 Polymeric delivery formulations of leuprolide with improved efficacy
09/16/2010US20100234301 Methods and Compositions for the Treatment of Gastrointestinal Disorders
09/16/2010US20100234293 Novel Neurotrophic Factors
09/16/2010US20100233249 Contraceptive methods and compositions related to proteasomal interference
09/14/2010US7795266 Tetrahydroindolone derivatives for treament of neurological conditions
09/14/2010US7795242 The antigens are associated with recognition of CD1 molecules by T cells. These antigens can be used as antigens, adjuvants or as immunomodulatory agents in a variety of therapeutic and prophylactic applications
09/09/2010US20100227849 Leukemia treatment method and composition
09/09/2010US20100226954 Polymeric delivery formulations of leuprolide with improved efficacy
09/09/2010US20100226941 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides
09/08/2010EP2226072A1 Combinations of suberoylanilide hydroxamic acid and antimetbolic agents for treating cancer
09/08/2010CN1798746B Reverse-turn mimetics and method relating thereto
09/08/2010CN1754002B Compositions concerning poxviruses and cancer and its preparation method
09/07/2010US7790854 antibody zeta -C2 raised against the sequence set forth in SEQ ID NO:2, which specifically binds to the atypical isoform protein kinase M zeta (PKM zeta ); Alzheimer's disease (AD) and neuroblastoma; using aPKC in diagnosis, drug screening and gene therapy
09/07/2010US7790704 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
09/07/2010US7790681 Binding to receptor of glucagon-like peptide; congestive heart failure
09/07/2010US7790205 administering to mammal a composition comprising a first component selected from dihydro-isohumulone, dihydro-isocohumulone, dihydro-isoadhumulone, tetrahydro-isohumulone, tetrahydro-isocohumulone, a second component selected from the group consisting of rosemary, an extract derived from rosemary
09/07/2010CA2512193C 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
09/02/2010US20100222591 New Compounds
09/02/2010US20100222376 Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders
09/02/2010US20100222330 New Compounds
09/02/2010US20100222298 Spill resistant formulations containing clays
09/02/2010US20100221264 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
09/01/2010EP2223682A1 Stable pharmaceutical solution formulations for pressurised metered dose inhalers
09/01/2010EP1613347B1 Humanized antibodies that recognize beta amyloid peptide
09/01/2010EP1594854B1 Thiazolyl-based compounds useful as kinase inhibitors
09/01/2010EP1560488B1 Antibacterial agents
09/01/2010CN101816658A HIV inhibiting pyrimidines derivatives
08/2010
08/31/2010US7785801 Identification of surface-associated antigens for tumor diagnosis and therapy
08/31/2010CA2549558C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/26/2010US20100216824 Anti-cancer cyclopenta [G]quinazonline compounds
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/25/2010EP2221064A1 Humanized antibodies that recognize beta amyloid peptide
08/25/2010EP2221052A2 Compositions that treat or inhibit pathological conditions associated with inflammatory response
08/25/2010EP1789083B1 Prevention of allergy in children
08/25/2010CN1951411B Nitric oxide and its biomedical significance
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/24/2010US7781442 N-phenyl-1,3-thiazol-2-amine derivatives, useful in the treatment of neurodegenerative disorders, such as Alzheimer's disease
08/24/2010US7781414 Targets for tumor growth inhibition
08/19/2010US20100210693 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
08/19/2010US20100210677 Novel compound, corresponding compositions, preparation and/or treatment methods
08/19/2010US20100210510 Oral lactoferrin in the treatment of sepsis
08/18/2010CN101804200A Broad spectrum anti-viral therapeutics and prophylaxis
08/17/2010US7777051 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic
08/17/2010US7777025 for treating a mammal with a ricin toxin-A-antibody immunotoxin; comprise the sequence (d)GX(d)GA, where (d)G is either G or dG and X is an adenosine analog of the transition state of ricin toxin-A
08/17/2010US7777000 Anti-viral activity of cathelicidin peptides
08/17/2010US7776820 Methods for decreasing risk of complications of prematurity using IGF-I and its analogs
08/17/2010US7776527 identifying a test agent as reducing apoptosis of a macrophage cell; reducing the activity of Protein Kinase R
08/17/2010US7776368 protective devices comprising flexible impervious elastomers having powders of plant extracts on the surfaces
08/17/2010CA2385269C Novel thiazolo(4,5-d)pyrimidine compounds
08/12/2010US20100204254 Use of statins in the prevention and treatment of radiation injury and other disorders associated with reduced endothelial thrombomodulin
08/12/2010US20100204200 Inhibitors of cathepsin s
08/12/2010US20100204147 Methods For Delivering Thymosin Beta 4, Analogues, Isoforms and Other Derivatives
08/12/2010US20100203107 Methods of Administering a Dermatological Agent to a Subject
08/12/2010US20100203036 Targets for tumor growth inhibition
08/11/2010EP2216407A2 Therapeutic Compositions
08/11/2010EP1911763B1 Compositions for the treatment of gastrointestinal disorders
08/11/2010EP1200106B2 Composition containing extracts of butyrospermum parkii and the use as medicament
08/11/2010CN1913897B Novel compound, corresponding compositions, preparation and/or treatment methods
08/10/2010US7772234 Bicyclic inhibitors of MEK and methods of use thereof
08/10/2010US7772229 Oxabispidine compounds useful in the treatment of cardiac arrhythmias
08/10/2010US7772199 Forms of 5-azacytidine
08/10/2010US7772187 Substances directed against a specific sequence essential for heparanase catalytic activity and uses thereof as heparanase inhibitors
08/10/2010US7771982 lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions; lactobacilli, bifidobacteria or Enterococci
08/10/2010CA2530583C The polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid
08/10/2010CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/10/2010CA2451605C Diamine derivatives
08/05/2010US20100197756 Indole-3-Sulphur Derivatives
08/05/2010US20100197701 Method of treating diabetes
08/05/2010US20100197648 Treatment of irritable bowel syndrome and related bowel disease
08/05/2010US20100197627 Pancreatic cancer treatment
08/05/2010US20100196372 FcgammaRIIB Fusion Proteins and Compositions Thereof
08/04/2010EP2213661A1 c-Met Modulators and Methods of Use
08/04/2010EP2213295A1 A method for obtaining data useful in the identification of a patient at risk of having difficulty in sustaining a pregnancy
08/04/2010EP2213279A2 Improvements in and relating to carrier particles for use in dry powder inhalers
08/04/2010EP1608344B1 Oral formulations of cladribine
08/04/2010CN101792415A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/04/2010CN101791409A peptide vectors
08/03/2010US7767676 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 295